Cargando…

Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy

Aim of the Study: To demonstrate general progression of symptoms in cervical dystonia (CD) on the one hand and improvement of some special symptoms on the other hand after botulinum toxin (BoNT) therapy. Methods: 74 patients with idiopathic CD under continuous treatment in a BoNT outpatient departme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hefter, Harald, Schomaecker, Isabelle, Schomaecker, Max, Samadzadeh, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689059/ https://www.ncbi.nlm.nih.gov/pubmed/33281726 http://dx.doi.org/10.3389/fneur.2020.588395

Ejemplares similares

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia
por: Hefter, Harald, et al.
Publicado: (2021)

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study
por: Hefter, Harald, et al.
Publicado: (2022)

Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study
por: Hefter, Harald, et al.
Publicado: (2023)

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
por: Hefter, Harald, et al.
Publicado: (2021)

The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia
por: Samadzadeh, Sara, et al.
Publicado: (2020)

Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study
por: Hefter, Harald, et al.
Publicado: (2023)

Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis
por: Hefter, Harald, et al.
Publicado: (2013)

The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2020)

The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2022)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

“Pseudo”-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study
por: Hefter, Harald, et al.
Publicado: (2023)

An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
por: Hefter, H, et al.
Publicado: (2013)

Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection
por: Hu, Yaowen, et al.
Publicado: (2022)

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy
por: Jost, Wolfgang H., et al.
Publicado: (2012)

Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins
por: Ameer, Muhammad Atif, et al.
Publicado: (2021)

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study
por: Misra, Vijay P, et al.
Publicado: (2012)

White Matter Changes in Cervical Dystonia Relate to Clinical Effectiveness of Botulinum Toxin Treatment
por: Blood, Anne J., et al.
Publicado: (2019)

Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure
por: Hefter, Harald, et al.
Publicado: (2022)

Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2019)

Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement
por: Schramm, Axel, et al.
Publicado: (2014)

The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany
por: Samadzadeh, Sara, et al.
Publicado: (2021)

The Necessity of a Locally Active Antidote in the Clinical Practice of Botulinum Neurotoxin Therapy: Short Communication
por: Hefter, Harald, et al.
Publicado: (2022)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

Comparing soleus injections and gastrocnemius injections of botulinum toxin for treating adult spastic foot drop: a monocentric observational study
por: Hefter, Harald, et al.
Publicado: (2021)

A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis
por: Hefter, Harald, et al.
Publicado: (2011)

Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report
por: Hefter, Harald, et al.
Publicado: (2021)

Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2014)

Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review
por: Hefter, Harald, et al.
Publicado: (2021)

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop
por: Hefter, Harald, et al.
Publicado: (2021)

Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review
por: Erro, Roberto, et al.
Publicado: (2023)

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study
por: Kutschenko, Anna, et al.
Publicado: (2020)

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
por: Dressler, Dirk, et al.
Publicado: (2021)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia
por: Costanzo, Matteo, et al.
Publicado: (2021)

The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
por: Fietzek, Urban M., et al.
Publicado: (2021)

Tremor in Idiopathic Cervical Dystonia – Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification
por: Pandey, Sanjay, et al.
Publicado: (2020)

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study
por: Drexel, S. C., et al.
Publicado: (2019)

Shear wave elastography combined with electromyography to assess the effect of botulinum toxin on spastic dystonia following stroke: A pilot study
por: Campanella, William, et al.
Publicado: (2022)

Multimodal Quantitative MRI Reveals No Evidence for Tissue Pathology in Idiopathic Cervical Dystonia
por: Gracien, René-Maxime, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8n3flup2cf2988v0tcsq5s21q4